Trial Profile
Multicentric trial comparing three therapeutical strategies in patients with acute primary HIV infections. ANRS 112 INTERPRIM
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms INTERPRIM
- 06 Sep 2006 Status change
- 14 Nov 2005 New trial record.